| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.896 | 0.002 | 0.896 | 5 Hydroxytryptamine release stimulant | 0.86 0.002 CID_104223 | ||
| 0.617 | 0.003 | 0.617 | 5 Hydroxytryptamine uptake stimulant | 0.394 0.015 CID_104223 | ||
| 0.572 | 0.032 | 0.572 | Analgesic | 0.521 0.043 CID_104223 | ||
| 0.537 | 0.022 | 0.537 | 5 Hydroxytryptamine release inhibitor | 0.435 0.059 CID_104223 | ||
| 0.494 | 0.011 | 0.494 | Psychostimulant | 0.354 0.031 CID_104223 | ||
| 0.512 | 0.035 | 0.512 | Antiobesity | 0.258 0.149 CID_104223 | ||
| 0.46 | 0.017 | 0.46 | Superoxide dismutase inhibitor | 0.446 0.019 CID_104223 | ||
| 0.409 | 0.007 | 0.409 | Tyrosine 3 hydroxylase inhibitor | 0.323 0.024 CID_104223 | ||
| 0.4 | 0.005 | 0.4 | 5 Hydroxytryptamine 1F antagonist | 0.102 0.03 CID_104223 | ||
| 0.399 | 0.005 | 0.399 | 5 Hydroxytryptamine agonist | 0.347 0.007 CID_104223 | ||
| 0.451 | 0.06 | 0.492 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.492 0.037 CID_104223 | CID_104223 | |
| 0.404 | 0.079 | 0.453 | Calcium channel L-type activator | 0.453 0.049 CID_104223 | CID_104223 | |
| 0.354 | 0.033 | 0.354 | Insulysin inhibitor | 0.338 0.039 CID_104223 | ||
| 0.315 | 0.003 | 0.315 | 5 Hydroxytryptamine 2A agonist | 0.252 0.004 CID_104223 | ||
| 0.378 | 0.069 | 0.378 | Transcription factor NF kappa B inhibitor | 0.345 0.079 CID_104223 | ||
| 0.362 | 0.059 | 0.362 | Cholesterol antagonist | 0.326 0.076 CID_104223 | ||
| 0.402 | 0.11 | 0.455 | Caspase 9 stimulant | 0.455 0.08 CID_104223 | CID_104223 | |
| 0.315 | 0.047 | 0.315 | Antiamyloidogenic | 0.2 0.099 CID_104223 | ||
| 0.286 | 0.022 | 0.286 | Neurotrophic factor enhancer | 0.284 0.023 CID_104223 | ||
| 0.283 | 0.028 | 0.283 | Neuropeptide Y2 antagonist | 0.27 0.038 CID_104223 | ||
| 0.279 | 0.037 | 0.279 | Growth hormone agonist | 0.181 0.067 CID_104223 | ||
| 0.357 | 0.117 | 0.357 | Cyclophilin D inhibitor | 0.284 0.177 CID_104223 | ||
| 0.266 | 0.026 | 0.266 | Insulin sensitizer | 0.248 0.036 CID_104223 | ||
| 0.237 | 0.004 | 0.237 | 5 Hydroxytryptamine 2 agonist | 0.183 0.004 CID_104223 | ||
| 0.298 | 0.075 | 0.298 | Interleukin 2 agonist | 0.257 0.111 CID_104223 | ||
| 0.221 | 0.004 | 0.221 | 5 Hydroxytryptamine 2C agonist | 0.081 0.011 CID_104223 | ||
| 0.302 | 0.09 | 0.409 | Calcium channel activator | 0.409 0.021 CID_104223 | CID_104223 | |
| 0.229 | 0.026 | 0.272 | Nav1.2 sodium channel blocker | 0.272 0.018 CID_104223 | CID_104223 | |
| 0.258 | 0.057 | 0.258 | Calpain inhibitor | 0.202 0.112 CID_104223 | ||
| 0.205 | 0.007 | 0.306 | CYP2A6 inhibitor | 0.306 0.004 CID_104223 | CID_104223 | |
| 0.215 | 0.018 | 0.215 | Aminopeptidase B inhibitor | 0.167 0.031 CID_104223 | ||
| 0.265 | 0.068 | 0.265 | Interleukin agonist | 0.201 0.12 CID_104223 | ||
| 0.205 | 0.009 | 0.205 | Sphingosine 1-phosphate receptor 5 antagonist | 0.193 0.015 CID_104223 | ||
| 0.195 | 0.01 | 0.24 | Nitric-oxide synthase inhibitor | 0.24 0.005 CID_104223 | CID_104223 | |
| 0.221 | 0.036 | 0.234 | Antipruritic | 0.234 0.03 CID_104223 | CID_104223 | |
| 0.24 | 0.055 | 0.256 | Anesthetic general | 0.256 0.048 CID_104223 | CID_104223 | |
| 0.218 | 0.034 | 0.218 | Thiol protease inhibitor | 0.182 0.047 CID_104223 | ||
| 0.281 | 0.104 | 0.281 | Vasodilator, coronary | 0.281 0.104 CID_104223 | ||
| 0.194 | 0.016 | 0.194 | Catalase inhibitor | 0.07 0.055 CID_104223 | ||
| 0.188 | 0.011 | 0.19 | Sphingosine 1-phosphate receptor 2 antagonist | 0.19 0.011 CID_104223 | CID_104223 | |
| 0.199 | 0.023 | 0.199 | Cathepsin H inhibitor | 0.137 0.057 CID_104223 | ||
| 0.182 | 0.006 | 0.182 | Glycine transporter 2 inhibitor | 0.145 0.008 CID_104223 | ||
| 0.241 | 0.065 | 0.241 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.171 0.117 CID_104223 | ||
| 0.192 | 0.018 | 0.192 | Ca(v)2.2 blocker | 0.168 0.024 CID_104223 | ||
| 0.195 | 0.021 | 0.195 | Nav1.6 sodium channel blocker | 0.195 0.021 CID_104223 | ||
| 0.226 | 0.053 | 0.26 | Nitric-oxide synthase stimulant | 0.26 0.026 CID_104223 | CID_104223 | |
| 0.215 | 0.042 | 0.293 | 5 Hydroxytryptamine 3E antagonist | 0.293 0.005 CID_104223 | CID_104223 | |
| 0.255 | 0.083 | 0.264 | Transcription factor STAT inhibitor | 0.264 0.078 CID_104223 | CID_104223 | |
| 0.175 | 0.003 | 0.175 | 5 Hydroxytryptamine 2B agonist | 0.148 0.003 CID_104223 | ||
| 0.191 | 0.019 | 0.191 | Calcium channel N-type blocker | 0.149 0.038 CID_104223 | ||
| 0.252 | 0.082 | 0.252 | Transcription factor STAT3 inhibitor | 0.234 0.097 CID_104223 | ||
| 0.294 | 0.127 | 0.294 | Histamine release inhibitor | 0.259 0.149 CID_104223 | ||
| 0.167 | 0.005 | 0.184 | Neurokinin antagonist | 0.184 0.005 CID_104223 | CID_104223 | |
| 0.225 | 0.064 | 0.251 | MAP kinase kinase 3 inhibitor | 0.251 0.031 CID_104223 | CID_104223 | |
| 0.189 | 0.028 | 0.287 | Adenylate cyclase inhibitor | 0.287 0.015 CID_104223 | CID_104223 | |
| 0.163 | 0.005 | 0.189 | Neurokinin 1 antagonist | 0.189 0.004 CID_104223 | CID_104223 | |
| 0.167 | 0.009 | 0.238 | Phenylalanine 4-hydroxylase inhibitor | 0.238 0.005 CID_104223 | CID_104223 | |
| 0.166 | 0.01 | 0.166 | Aminopeptidase I inhibitor | 0.106 0.025 CID_104223 | ||
| 0.193 | 0.039 | 0.193 | Neurotensin receptor agonist | 0.179 0.051 CID_104223 | ||
| 0.159 | 0.005 | 0.168 | Substance P antagonist | 0.168 0.004 CID_104223 | CID_104223 | |
| 0.161 | 0.007 | 0.161 | Sphingosine 1-phosphate receptor 4 agonist | 0.148 0.009 CID_104223 | ||
| 0.166 | 0.014 | 0.166 | DOPA decarboxylase inhibitor | 0.127 0.038 CID_104223 | ||
| 0.224 | 0.072 | 0.224 | Interleukin antagonist | 0.209 0.079 CID_104223 | ||
| 0.23 | 0.079 | 0.23 | Angiogenesis stimulant | |||
| 0.163 | 0.013 | 0.25 | Inducible nitric-oxide synthase inhibitor | 0.25 0.005 CID_104223 | CID_104223 | |
| 0.278 | 0.129 | 0.278 | Immunosuppressant | |||
| 0.169 | 0.022 | 0.169 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.1 0.054 CID_104223 | ||
| 0.184 | 0.042 | 0.196 | Cytokine production inhibitor | 0.196 0.037 CID_104223 | CID_104223 | |
| 0.146 | 0.004 | 0.146 | Sphingosine kinase 2 inhibitor | 0.123 0.005 CID_104223 | ||
| 0.164 | 0.023 | 0.167 | Heat shock protein 70 antagonist | 0.167 0.02 CID_104223 | CID_104223 | |
| 0.18 | 0.041 | 0.18 | Alpha-N-acetylglucosaminidase inhibitor | 0.138 0.063 CID_104223 | ||
| 0.246 | 0.107 | 0.282 | Ca(v)3.3 blocker | 0.282 0.059 CID_104223 | CID_104223 | |
| 0.163 | 0.026 | 0.163 | Interleukin 8 antagonist | 0.142 0.039 CID_104223 | ||
| 0.15 | 0.014 | 0.15 | Nav1.8 sodium channel blocker | 0.098 0.029 CID_104223 | ||
| 0.162 | 0.028 | 0.163 | Vanilloid 1 agonist | 0.163 0.028 CID_104223 | CID_104223 | |
| 0.159 | 0.025 | 0.16 | Ca2+-transporting ATPase inhibitor | 0.16 0.023 CID_104223 | CID_104223 | |
| 0.171 | 0.039 | 0.179 | Toll-Like receptor 2 antagonist | 0.179 0.034 CID_104223 | CID_104223 | |
| 0.188 | 0.058 | 0.188 | Thrombolytic | 0.143 0.087 CID_104223 | ||
| 0.157 | 0.028 | 0.157 | Sphingosine 1-phosphate receptor 4 antagonist | 0.143 0.04 CID_104223 | ||
| 0.188 | 0.059 | 0.188 | 3C-like protease (Human coronavirus) inhibitor | 0.153 0.096 CID_104223 | ||
| 0.151 | 0.024 | 0.151 | Creatine kinase inhibitor | 0.144 0.026 CID_104223 | ||
| 0.162 | 0.036 | 0.162 | 5 Hydroxytryptamine 2B antagonist | 0.156 0.038 CID_104223 | ||
| 0.264 | 0.139 | 0.264 | Calpain 2 inhibitor | |||
| 0.226 | 0.102 | 0.226 | Spasmolytic | 0.223 0.104 CID_104223 | ||
| 0.173 | 0.05 | 0.196 | MAO inhibitor | 0.196 0.042 CID_104223 | CID_104223 | |
| 0.166 | 0.044 | 0.172 | Sodium channel (voltage-gated) blocker | 0.172 0.041 CID_104223 | CID_104223 | |
| 0.156 | 0.035 | 0.194 | Ferrochelatase inhibitor | 0.194 0.024 CID_104223 | CID_104223 | |
| 0.163 | 0.044 | 0.205 | Adenylate cyclase stimulant | 0.205 0.011 CID_104223 | CID_104223 | |
| 0.166 | 0.047 | 0.18 | Sodium channel blocker | 0.18 0.041 CID_104223 | CID_104223 | |
| 0.168 | 0.05 | 0.195 | Hemostatic | 0.195 0.034 CID_104223 | CID_104223 | |
| 0.134 | 0.017 | 0.201 | Glutamate decarboxylase inhibitor | 0.201 0.007 CID_104223 | CID_104223 | |
| 0.121 | 0.004 | 0.121 | Glutamate (mGluR3) antagonist | 0.069 0.006 CID_104223 | ||
| 0.13 | 0.016 | 0.133 | Glutamate release inhibitor | 0.133 0.015 CID_104223 | CID_104223 | |
| 0.146 | 0.032 | 0.243 | GABA C receptor antagonist | 0.243 0.007 CID_104223 | CID_104223 | |
| 0.119 | 0.005 | 0.154 | Exportin-1 inhibitor | 0.154 0.003 CID_104223 | CID_104223 | |
| 0.172 | 0.058 | 0.206 | Phospholipase A2 inhibitor | 0.206 0.039 CID_104223 | CID_104223 | |
| 0.179 | 0.066 | 0.179 | Peroxidase inhibitor | 0.145 0.08 CID_104223 | ||
| 0.121 | 0.01 | 0.121 | Secretase beta inhibitor | 0.076 0.041 CID_104223 | ||
| 0.116 | 0.005 | 0.116 | Sphingosine kinase inhibitor | 0.087 0.012 CID_104223 | ||
| 0.195 | 0.086 | 0.349 | Anticonvulsant | 0.349 0.029 CID_104223 | CID_104223 | |
| 0.14 | 0.031 | 0.16 | Potassium channel (Ca-activated) activator | 0.16 0.025 CID_104223 | CID_104223 | |
| 0.113 | 0.005 | 0.113 | Glutamate (mGluR7) antagonist | 0.098 0.012 CID_104223 | ||
| 0.114 | 0.006 | 0.227 | Kinesin antagonist | 0.227 0.004 CID_104223 | CID_104223 | |
| 0.114 | 0.006 | 0.227 | Kinesin-like protein 1 inhibitor | 0.227 0.004 CID_104223 | CID_104223 | |
| 0.137 | 0.03 | 0.168 | 5 Hydroxytryptamine 2C antagonist | 0.168 0.023 CID_104223 | CID_104223 | |
| 0.242 | 0.136 | 0.242 | Apoptosis antagonist | 0.224 0.152 CID_104223 | ||
| 0.139 | 0.035 | 0.186 | Nav1.5 sodium channel blocker | 0.186 0.015 CID_104223 | CID_104223 | |
| 0.141 | 0.038 | 0.354 | GABA C receptor agonist | 0.354 0.007 CID_104223 | CID_104223 | |
| 0.186 | 0.083 | 0.186 | Non-steroidal antiinflammatory agent | 0.169 0.096 CID_104223 | ||
| 0.125 | 0.021 | 0.125 | Somatostatin 1 agonist | 0.096 0.037 CID_104223 | ||
| 0.111 | 0.009 | 0.111 | Neurokinin 2 antagonist | 0.105 0.01 CID_104223 | ||
| 0.168 | 0.066 | 0.168 | Interleukin 6 antagonist | 0.156 0.081 CID_104223 | ||
| 0.269 | 0.168 | 0.419 | MAP kinase kinase 6 inhibitor | 0.419 0.048 CID_104223 | CID_104223 | |
| 0.148 | 0.047 | 0.148 | Proteasome inhibitor | |||
| 0.123 | 0.025 | 0.149 | Histidine decarboxylase inhibitor | 0.149 0.02 CID_104223 | CID_104223 | |
| 0.137 | 0.04 | 0.137 | Nav1.4 sodium channel blocker | 0.104 0.07 CID_104223 | ||
| 0.108 | 0.013 | 0.108 | Protease 3C (Human rhinovirus) inhibitor | 0.075 0.032 CID_104223 | ||
| 0.121 | 0.025 | 0.13 | Ornithine decarboxylase inhibitor | 0.13 0.019 CID_104223 | CID_104223 | |
| 0.136 | 0.042 | 0.136 | Calcium channel (voltage-sensitive) blocker | 0.131 0.046 CID_104223 | ||
| 0.129 | 0.037 | 0.131 | Adenylate kinase inhibitor | 0.131 0.036 CID_104223 | CID_104223 | |
| 0.232 | 0.141 | 0.232 | Antithrombotic | 0.206 0.17 CID_104223 | ||
| 0.143 | 0.053 | 0.15 | Nav1.3 sodium channel blocker | 0.15 0.048 CID_104223 | CID_104223 | |
| 0.117 | 0.026 | 0.117 | Opioid delta receptor antagonist | |||
| 0.166 | 0.076 | 0.166 | ATPase inhibitor | 0.154 0.095 CID_104223 | ||
| 0.149 | 0.059 | 0.174 | Calcium channel blocker | 0.174 0.042 CID_104223 | CID_104223 | |
| 0.15 | 0.061 | 0.15 | Histone deacetylase SIRT1 inhibitor | 0.146 0.065 CID_104223 | ||
| 0.116 | 0.028 | 0.116 | Glutamate receptor agonist | 0.094 0.042 CID_104223 | ||
| 0.104 | 0.018 | 0.104 | Protein kinase C iota inhibitor | |||
| 0.118 | 0.032 | 0.168 | Lanosterol 14 alpha demethylase inhibitor | 0.168 0.007 CID_104223 | CID_104223 | |
| 0.13 | 0.044 | 0.154 | Transcription factor STAT6 inhibitor | 0.154 0.02 CID_104223 | CID_104223 | |
| 0.119 | 0.035 | 0.121 | Alcohol dehydrogenase inhibitor | 0.121 0.034 CID_104223 | CID_104223 | |
| 0.105 | 0.021 | 0.118 | Potassium channel large-conductance Ca-activated activator | 0.118 0.017 CID_104223 | CID_104223 | |
| 0.093 | 0.01 | 0.093 | Sphingosine 1-phosphate receptor 3 antagonist | 0.079 0.018 CID_104223 | ||
| 0.108 | 0.025 | 0.108 | Neuropeptide agonist | 0.063 0.037 CID_104223 | ||
| 0.093 | 0.011 | 0.135 | Potassium channel intermediate-conductance Ca-activated blocker | 0.135 0.005 CID_104223 | CID_104223 | |
| 0.086 | 0.003 | 0.097 | Histamine H1 receptor agonist | 0.097 0.002 CID_104223 | CID_104223 | |
| 0.122 | 0.04 | 0.174 | Sphingomyelinase inhibitor | 0.174 0.016 CID_104223 | CID_104223 | |
| 0.088 | 0.006 | 0.088 | Glutamate (mGluR group III) antagonist | 0.063 0.012 CID_104223 | ||
| 0.12 | 0.039 | 0.12 | Factor V inhibitor | 0.092 0.091 CID_104223 | ||
| 0.125 | 0.044 | 0.125 | Protease inhibitor | |||
| 0.128 | 0.047 | 0.128 | Mucolytic | 0.104 0.071 CID_104223 | ||
| 0.134 | 0.054 | 0.168 | Beta amyloid protein antagonist | 0.168 0.029 CID_104223 | CID_104223 | |
| 0.084 | 0.005 | 0.084 | Sphingosine kinase 1 inhibitor | 0.054 0.013 CID_104223 | ||
| 0.106 | 0.028 | 0.106 | Glutamate dehydrogenase inhibitor | 0.102 0.03 CID_104223 | ||
| 0.088 | 0.01 | 0.125 | Epithelial sodium channel blocker | 0.125 0.004 CID_104223 | CID_104223 | |
| 0.123 | 0.045 | 0.292 | Carbonic anhydrase XV inhibitor | 0.292 0.008 CID_104223 | CID_104223 | |
| 0.153 | 0.077 | 0.153 | Melanin inhibitor | 0.149 0.083 CID_104223 | ||
| 0.08 | 0.004 | 0.08 | Glutamate (mGluR1) agonist | 0.025 0.015 CID_104223 | ||
| 0.083 | 0.008 | 0.083 | Glutamate (mGluR4) antagonist | 0.065 0.012 CID_104223 | ||
| 0.117 | 0.042 | 0.167 | HIV-1 integrase (Overall Integration) inhibitor | 0.167 0.02 CID_104223 | CID_104223 | |
| 0.114 | 0.039 | 0.114 | Opioid antagonist | |||
| 0.103 | 0.029 | 0.103 | Protein kinase B alpha inhibitor | |||
| 0.097 | 0.023 | 0.106 | Glycine receptor agonist | 0.106 0.018 CID_104223 | CID_104223 | |
| 0.092 | 0.019 | 0.092 | Purinergic P2X1 antagonist | 0.089 0.02 CID_104223 | ||
| 0.093 | 0.021 | 0.093 | Adrenaline uptake inhibitor | |||
| 0.081 | 0.008 | 0.217 | TRPM8 blocker | 0.217 0.004 CID_104223 | CID_104223 | |
| 0.105 | 0.033 | 0.105 | Glutathione S-transferase inhibitor | 0.079 0.062 CID_104223 | ||
| 0.085 | 0.012 | 0.085 | Dipeptidyl peptidase inhibitor | 0.062 0.024 CID_104223 | ||
| 0.085 | 0.013 | 0.085 | Corticotropin releasing factor 2 receptor antagonist | 0.085 0.013 CID_104223 | ||
| 0.149 | 0.078 | 0.17 | CF transmembrane conductance regulator agonist | 0.17 0.046 CID_104223 | CID_104223 | |
| 0.073 | 0.003 | 0.073 | Tryptophan 5 hydroxylase inhibitor | 0.054 0.005 CID_104223 | ||
| 0.092 | 0.022 | 0.128 | NMDA receptor agonist | 0.128 0.011 CID_104223 | CID_104223 | |
| 0.194 | 0.124 | 0.194 | Immunostimulant | |||
| 0.094 | 0.026 | 0.094 | Sphingosine 1-phosphate receptor antagonist | 0.081 0.043 CID_104223 | ||
| 0.073 | 0.005 | 0.073 | Dipeptidyl peptidase II inhibitor | 0.067 0.006 CID_104223 | ||
| 0.11 | 0.043 | 0.11 | Glutamate (mGluR7) agonist | 0.106 0.048 CID_104223 | ||
| 0.12 | 0.053 | 0.12 | Falcipain 3 inhibitor | |||
| 0.085 | 0.019 | 0.085 | Glutamate (mGluR6) antagonist | 0.066 0.049 CID_104223 | ||
| 0.088 | 0.022 | 0.088 | Argininosuccinate synthase inhibitor | 0.051 0.046 CID_104223 | ||
| 0.075 | 0.01 | 0.123 | Adenylate cyclase 1 inhibitor | 0.123 0.003 CID_104223 | CID_104223 | |
| 0.076 | 0.011 | 0.076 | Lysophosphatidic acid 3 receptor antagonist | 0.06 0.022 CID_104223 | ||
| 0.07 | 0.005 | 0.07 | Glutamate (mGluR8) agonist | 0.057 0.008 CID_104223 | ||
| 0.101 | 0.036 | 0.11 | Adrenaline agonist | 0.11 0.031 CID_104223 | CID_104223 | |
| 0.1 | 0.035 | 0.231 | Myeloperoxidase inhibitor | 0.231 0.004 CID_104223 | CID_104223 | |
| 0.086 | 0.022 | 0.086 | Potassium channel (Tandem pore domain) blocker | 0.084 0.026 CID_104223 | ||
| 0.078 | 0.014 | 0.078 | Sphingosine 1-phosphate receptor 1 antagonist | 0.063 0.024 CID_104223 | ||
| 0.106 | 0.043 | 0.193 | NMDA receptor antagonist | 0.193 0.015 CID_104223 | CID_104223 | |
| 0.094 | 0.032 | 0.127 | GABA aminotransferase inhibitor | 0.127 0.013 CID_104223 | CID_104223 | |
| 0.135 | 0.074 | 0.146 | Neurotrophic factor | 0.146 0.063 CID_104223 | CID_104223 | |
| 0.204 | 0.143 | 0.204 | Gastrin inhibitor | |||
| 0.116 | 0.054 | 0.116 | MAO A inhibitor | |||
| 0.119 | 0.058 | 0.126 | Photosensitizer | 0.126 0.05 CID_104223 | CID_104223 | |
| 0.096 | 0.035 | 0.096 | Cathepsin G inhibitor | |||
| 0.184 | 0.125 | 0.184 | RNA-directed DNA polymerase inhibitor | 0.174 0.145 CID_104223 | ||
| 0.071 | 0.012 | 0.071 | Kainate receptor antagonist | 0.047 0.023 CID_104223 | ||
| 0.149 | 0.091 | 0.188 | Protein kinase (CK1) gamma 3 inhibitor | 0.188 0.055 CID_104223 | CID_104223 | |
| 0.097 | 0.038 | 0.097 | Chymotrypsin inhibitor | |||
| 0.093 | 0.034 | 0.093 | Opioid mu receptor antagonist | |||
| 0.093 | 0.035 | 0.122 | Estrogen-related receptor beta agonist | 0.122 0.009 CID_104223 | CID_104223 | |
| 0.067 | 0.01 | 0.067 | Dipeptidyl peptidase IV inhibitor | 0.044 0.031 CID_104223 | ||
| 0.106 | 0.049 | 0.106 | Prolactin inhibitor | 0.102 0.053 CID_104223 | ||
| 0.066 | 0.01 | 0.07 | Sphingosine 1-phosphate receptor 1 agonist | 0.07 0.008 CID_104223 | CID_104223 | |
| 0.074 | 0.018 | 0.074 | Bombesin 2 receptor antagonist | 0.057 0.026 CID_104223 | ||
| 0.084 | 0.029 | 0.107 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.107 0.01 CID_104223 | CID_104223 | |
| 0.061 | 0.006 | 0.061 | Kainate receptor agonist | 0.039 0.034 CID_104223 | ||
| 0.108 | 0.054 | 0.129 | Carbonic anhydrase III inhibitor | 0.129 0.038 CID_104223 | CID_104223 | |
| 0.073 | 0.019 | 0.073 | Dopamine transporter inhibitor | |||
| 0.107 | 0.053 | 0.107 | Anabolic | 0.099 0.064 CID_104223 | ||
| 0.079 | 0.026 | 0.104 | TRPA1 antagonist | 0.104 0.016 CID_104223 | CID_104223 | |
| 0.067 | 0.014 | 0.067 | Immunoglobulin Fc receptor antagonist | 0.062 0.021 CID_104223 | ||
| 0.071 | 0.018 | 0.073 | Beta 2 adrenoreceptor agonist | 0.073 0.014 CID_104223 | CID_104223 | |
| 0.065 | 0.012 | 0.083 | Histamine H2 receptor agonist | 0.083 0.006 CID_104223 | CID_104223 | |
| 0.086 | 0.034 | 0.103 | Calcium channel L-type blocker | 0.103 0.023 CID_104223 | CID_104223 | |
| 0.142 | 0.09 | 0.142 | Interferon gamma antagonist | |||
| 0.06 | 0.009 | 0.06 | Potassium channel Kv1.1 blocker | 0.04 0.023 CID_104223 | ||
| 0.137 | 0.086 | 0.137 | Neuropeptide Y1 antagonist | 0.128 0.104 CID_104223 | ||
| 0.065 | 0.016 | 0.071 | Neurokinin 3 antagonist | 0.071 0.012 CID_104223 | CID_104223 | |
| 0.097 | 0.048 | 0.105 | Aminoacyl-tRNA synthetase inhibitor | 0.105 0.04 CID_104223 | CID_104223 | |
| 0.075 | 0.027 | 0.075 | Cathepsin L inhibitor | 0.071 0.029 CID_104223 | ||
| 0.056 | 0.007 | 0.056 | Dipeptidyl peptidase I inhibitor | |||
| 0.058 | 0.01 | 0.149 | Diamine oxidase inhibitor | 0.149 0.003 CID_104223 | CID_104223 | |
| 0.161 | 0.114 | 0.161 | Focal adhesion kinase 2 inhibitor | |||
| 0.062 | 0.015 | 0.069 | Sphingosine 1-phosphate receptor agonist | 0.069 0.012 CID_104223 | CID_104223 | |
| 0.075 | 0.028 | 0.085 | Carbonic anhydrase stimulant | 0.085 0.024 CID_104223 | CID_104223 | |
| 0.056 | 0.01 | 0.056 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.055 0.01 CID_104223 | ||
| 0.134 | 0.088 | 0.144 | Pregnane X receptor agonist | 0.144 0.064 CID_104223 | CID_104223 | |
| 0.092 | 0.047 | 0.092 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.067 | 0.021 | 0.099 | Histamine agonist | 0.099 0.009 CID_104223 | CID_104223 | |
| 0.15 | 0.105 | 0.18 | Phospholipase C inhibitor | 0.18 0.061 CID_104223 | CID_104223 | |
| 0.099 | 0.055 | 0.118 | Interleukin 12 antagonist | 0.118 0.031 CID_104223 | CID_104223 | |
| 0.049 | 0.005 | 0.049 | Glutamate (mGluR1a) agonist | 0.028 0.01 CID_104223 | ||
| 0.16 | 0.116 | 0.166 | MAP kinase kinase 5 inhibitor | 0.166 0.096 CID_104223 | CID_104223 | |
| 0.073 | 0.029 | 0.073 | Bombesin 1 receptor agonist | |||
| 0.054 | 0.011 | 0.054 | Phenylethanolamine N methyltransferase inhibitor | 0.053 0.012 CID_104223 | ||
| 0.073 | 0.029 | 0.073 | Aminopeptidase microsomal inhibitor | |||
| 0.104 | 0.061 | 0.108 | Nav1.1 sodium channel blocker | 0.108 0.058 CID_104223 | CID_104223 | |
| 0.05 | 0.009 | 0.05 | AMPA receptor agonist | |||
| 0.119 | 0.078 | 0.127 | Cyclooxygenase 3 inhibitor | 0.127 0.07 CID_104223 | CID_104223 | |
| 0.074 | 0.033 | 0.093 | NMDA receptor glycine site agonist | 0.093 0.02 CID_104223 | CID_104223 | |
| 0.064 | 0.023 | 0.067 | Pregnane X receptor antagonist | 0.067 0.018 CID_104223 | CID_104223 | |
| 0.063 | 0.022 | 0.063 | Opioid mu receptor agonist | |||
| 0.086 | 0.046 | 0.094 | CC chemokine 5 receptor agonist | 0.094 0.03 CID_104223 | CID_104223 | |
| 0.057 | 0.018 | 0.057 | Dihydroorotase inhibitor | |||
| 0.071 | 0.031 | 0.071 | Plasminogen activator inhibitor | 0.061 0.038 CID_104223 | ||
| 0.099 | 0.06 | 0.173 | MAO B inhibitor | 0.173 0.03 CID_104223 | CID_104223 | |
| 0.056 | 0.017 | 0.057 | Cathepsin L1 inhibitor | 0.057 0.017 CID_104223 | CID_104223 | |
| 0.058 | 0.019 | 0.058 | Cathepsin L2 inhibitor | |||
| 0.057 | 0.019 | 0.057 | Oxytocin agonist | 0.057 0.019 CID_104223 | ||
| 0.059 | 0.021 | 0.059 | Potassium channel (Inward rectifier) activator | 0.046 0.045 CID_104223 | ||
| 0.084 | 0.046 | 0.089 | Nicotinic alpha4beta2 receptor antagonist | 0.089 0.041 CID_104223 | CID_104223 | |
| 0.052 | 0.014 | 0.052 | Glutamate (mGluR group II) antagonist | 0.041 0.023 CID_104223 | ||
| 0.082 | 0.045 | 0.082 | Analgesic, opioid | |||
| 0.11 | 0.072 | 0.152 | TRPA1 agonist | 0.152 0.029 CID_104223 | CID_104223 | |
| 0.071 | 0.034 | 0.071 | Carbamoyl phosphate synthetase inhibitor | 0.057 0.046 CID_104223 | ||
| 0.127 | 0.09 | 0.173 | Cell wall synthesis inhibitor | 0.173 0.045 CID_104223 | CID_104223 | |
| 0.052 | 0.015 | 0.052 | Kainate receptor 2 antagonist | 0.032 0.028 CID_104223 | ||
| 0.056 | 0.02 | 0.056 | Potassium channel (ATP-sensitive) activator | 0.044 0.043 CID_104223 | ||
| 0.053 | 0.017 | 0.077 | GABA B receptor antagonist | 0.077 0.007 CID_104223 | CID_104223 | |
| 0.046 | 0.01 | 0.046 | Glutamate (mGluR8) antagonist | 0.036 0.024 CID_104223 | ||
| 0.074 | 0.039 | 0.074 | Glucagon-like peptide 1 agonist | |||
| 0.061 | 0.026 | 0.061 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.064 | 0.029 | 0.064 | Ornithine carbamoyltransferase inhibitor | 0.055 0.035 CID_104223 | ||
| 0.045 | 0.011 | 0.051 | Endothelial nitric-oxide synthase inhibitor | 0.051 0.009 CID_104223 | CID_104223 | |
| 0.113 | 0.079 | 0.158 | Aldehyde dehydrogenase inhibitor | 0.158 0.043 CID_104223 | CID_104223 | |
| 0.065 | 0.031 | 0.065 | Human rhinovirus A protease inhibitor | |||
| 0.051 | 0.017 | 0.058 | Nerve growth factor antagonist | 0.058 0.01 CID_104223 | CID_104223 | |
| 0.07 | 0.037 | 0.08 | Aryl hydrocarbon receptor antagonist | 0.08 0.026 CID_104223 | CID_104223 | |
| 0.111 | 0.078 | 0.111 | Histone deacetylase class III inhibitor | 0.106 0.084 CID_104223 | ||
| 0.057 | 0.025 | 0.057 | Glutamate (mGluR group I) agonist | |||
| 0.062 | 0.031 | 0.062 | Kallikrein 1 inhibitor | |||
| 0.046 | 0.015 | 0.046 | Growth hormone releasing factor agonist | |||
| 0.061 | 0.029 | 0.061 | Elastase inhibitor | |||
| 0.036 | 0.005 | 0.036 | Protease (Human cytomegalovirus) inhibitor | 0.02 0.019 CID_104223 | ||
| 0.042 | 0.011 | 0.054 | Cholesterol ester transfer protein antagonist | 0.054 0.005 CID_104223 | CID_104223 | |
| 0.107 | 0.077 | 0.107 | Anesthetic local | |||
| 0.055 | 0.025 | 0.058 | Adenosine deaminase inhibitor | 0.058 0.023 CID_104223 | CID_104223 | |
| 0.064 | 0.035 | 0.066 | Dopamine uptake inhibitor | 0.066 0.033 CID_104223 | CID_104223 | |
| 0.099 | 0.07 | 0.099 | Expectorant | |||
| 0.098 | 0.069 | 0.115 | Urease inhibitor | 0.115 0.05 CID_104223 | CID_104223 | |
| 0.1 | 0.071 | 0.14 | 5 Hydroxytryptamine 2 antagonist | 0.14 0.048 CID_104223 | CID_104223 | |
| 0.105 | 0.076 | 0.133 | Interleukin 2 antagonist | 0.133 0.029 CID_104223 | CID_104223 | |
| 0.069 | 0.04 | 0.069 | 5 Hydroxytryptamine uptake inhibitor | |||
| 0.061 | 0.032 | 0.061 | Bombesin 3 receptor antagonist | |||
| 0.04 | 0.012 | 0.04 | Lysophosphatidic acid 2 receptor antagonist | |||
| 0.057 | 0.029 | 0.057 | Protease activated receptor 1 antagonist | |||
| 0.102 | 0.074 | 0.102 | Cystathionine beta-synthase inhibitor | |||
| 0.042 | 0.015 | 0.042 | Ceramide glucosyltransferase inhibitor | 0.037 0.021 CID_104223 | ||
| 0.064 | 0.037 | 0.075 | Histone deacetylase SIRT3 inhibitor | 0.075 0.022 CID_104223 | CID_104223 | |
| 0.089 | 0.062 | 0.089 | Potassium channel activator | 0.079 0.078 CID_104223 | ||
| 0.058 | 0.032 | 0.066 | Dihydroorotate oxidase inhibitor | 0.066 0.021 CID_104223 | CID_104223 | |
| 0.089 | 0.063 | 0.089 | Polo-like kinase-1 inhibitor | 0.082 0.08 CID_104223 | ||
| 0.038 | 0.012 | 0.038 | Glutamate (mGluR3) agonist | |||
| 0.055 | 0.03 | 0.055 | Prolyl endopeptidase inhibitor | |||
| 0.035 | 0.01 | 0.035 | Motilin receptor antagonist | |||
| 0.054 | 0.028 | 0.054 | Aminopeptidase N inhibitor | |||
| 0.126 | 0.101 | 0.166 | Acetylcholine M1 receptor antagonist | 0.166 0.061 CID_104223 | CID_104223 | |
| 0.062 | 0.037 | 0.062 | Cathepsin E inhibitor | |||
| 0.057 | 0.032 | 0.101 | NMDA 2A receptor antagonist | 0.101 0.013 CID_104223 | CID_104223 | |
| 0.037 | 0.013 | 0.037 | Thrombin receptor antagonist | 0.033 0.015 CID_104223 | ||
| 0.123 | 0.099 | 0.123 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | |||
| 0.032 | 0.008 | 0.032 | Aminopeptidase P inhibitor | |||
| 0.073 | 0.049 | 0.174 | NMDA 2 receptor antagonist | 0.174 0.012 CID_104223 | CID_104223 | |
| 0.058 | 0.034 | 0.058 | CC chemokine 2 receptor antagonist | 0.057 0.035 CID_104223 | ||
| 0.043 | 0.019 | 0.051 | Arginase inhibitor | 0.051 0.014 CID_104223 | CID_104223 | |
| 0.045 | 0.021 | 0.12 | Dopamine D5 agonist | 0.12 0.004 CID_104223 | CID_104223 | |
| 0.059 | 0.035 | 0.059 | Cathepsin D inhibitor | |||
| 0.083 | 0.06 | 0.083 | Factor XII inhibitor | |||
| 0.027 | 0.004 | 0.027 | Tryptophan hydroxylase 1 inhibitor | 0.016 0.015 CID_104223 | ||
| 0.041 | 0.018 | 0.041 | Opioid delta receptor agonist | |||
| 0.055 | 0.032 | 0.075 | Aconitate hydratase inhibitor | 0.075 0.016 CID_104223 | CID_104223 | |
| 0.051 | 0.028 | 0.051 | Bombesin antagonist | |||
| 0.033 | 0.011 | 0.034 | Calcium-sensing receptor agonist | 0.034 0.01 CID_104223 | CID_104223 | |
| 0.047 | 0.025 | 0.047 | Toll-Like receptor 2 agonist | 0.037 0.032 CID_104223 | ||
| 0.072 | 0.049 | 0.072 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.04 | 0.018 | 0.062 | Sirtuin 2 inhibitor | 0.062 0.009 CID_104223 | CID_104223 | |
| 0.046 | 0.024 | 0.046 | Erythropoietin receptor agonist | 0.036 0.033 CID_104223 | ||
| 0.051 | 0.03 | 0.074 | Glycine transporter inhibitor | 0.074 0.019 CID_104223 | CID_104223 | |
| 0.169 | 0.148 | 0.169 | Hypoglycemic | |||
| 0.055 | 0.034 | 0.055 | Opioid agonist | |||
| 0.03 | 0.01 | 0.03 | Kainate receptor 1 antagonist | |||
| 0.047 | 0.026 | 0.047 | Leukocyte elastase inhibitor | |||
| 0.177 | 0.157 | 0.177 | DNA synthesis inhibitor | |||
| 0.082 | 0.062 | 0.124 | Calcium antagonist | 0.124 0.033 CID_104223 | CID_104223 | |
| 0.091 | 0.071 | 0.091 | Bile acid receptor antagonist | |||
| 0.04 | 0.02 | 0.04 | Calcitonin receptor agonist | |||
| 0.028 | 0.008 | 0.028 | ICAM 1 antagonist | 0.025 0.012 CID_104223 | ||
| 0.061 | 0.042 | 0.066 | Heme oxygenase stimulant | 0.066 0.032 CID_104223 | CID_104223 | |
| 0.042 | 0.023 | 0.042 | Melanocortin 1 antagonist | 0.035 0.03 CID_104223 | ||
| 0.043 | 0.024 | 0.043 | Cathepsin F inhibitor | |||
| 0.068 | 0.049 | 0.07 | Phosphofructokinase-1 inhibitor | 0.07 0.048 CID_104223 | CID_104223 | |
| 0.091 | 0.073 | 0.124 | Electrolyte absorption antagonist | 0.124 0.033 CID_104223 | CID_104223 | |
| 0.038 | 0.02 | 0.038 | Fumarate hydratase inhibitor | 0.034 0.024 CID_104223 | ||
| 0.029 | 0.012 | 0.03 | Lysophosphatidic acid receptor 1 agonist | 0.03 0.011 CID_104223 | CID_104223 | |
| 0.032 | 0.014 | 0.055 | 5 Hydroxytryptamine 6 agonist | 0.055 0.004 CID_104223 | CID_104223 | |
| 0.047 | 0.03 | 0.047 | Baculoviral IAP repeat-containing protein inhibitor | |||
| 0.063 | 0.046 | 0.088 | Calcium channel P-type blocker | 0.088 0.009 CID_104223 | CID_104223 | |
| 0.042 | 0.025 | 0.042 | Somatostatin 1 antagonist | 0.039 0.027 CID_104223 | ||
| 0.056 | 0.039 | 0.056 | Cathepsin B inhibitor | |||
| 0.024 | 0.007 | 0.024 | Dipeptidyl peptidase IX inhibitor | |||
| 0.195 | 0.179 | 0.195 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.195 0.181 CID_104223 | ||
| 0.027 | 0.011 | 0.027 | Growth hormone release promoting | |||
| 0.151 | 0.135 | 0.196 | Hypolipemic | 0.196 0.097 CID_104223 | CID_104223 | |
| 0.029 | 0.014 | 0.029 | Methionyl aminopeptidase 2 inhibitor | |||
| 0.081 | 0.066 | 0.168 | Histamine N-methyltransferase inhibitor | 0.168 0.009 CID_104223 | CID_104223 | |
| 0.055 | 0.04 | 0.096 | 5 Hydroxytryptamine 7 agonist | 0.096 0.008 CID_104223 | CID_104223 | |
| 0.042 | 0.027 | 0.042 | Plasmepsin II inhibitor | 0.04 0.031 CID_104223 | ||
| 0.045 | 0.031 | 0.047 | Beta adrenoreceptor agonist | 0.047 0.026 CID_104223 | CID_104223 | |
| 0.087 | 0.074 | 0.111 | Potassium channel (Voltage-sensitive) activator | 0.111 0.041 CID_104223 | CID_104223 | |
| 0.031 | 0.018 | 0.031 | Glutamate (mGluR2) antagonist | 0.027 0.026 CID_104223 | ||
| 0.068 | 0.056 | 0.092 | Epoxide hydrolase inhibitor | 0.092 0.031 CID_104223 | CID_104223 | |
| 0.028 | 0.015 | 0.028 | Thyroid hormone agonist | |||
| 0.09 | 0.078 | 0.146 | GABA C receptor rho-1 antagonist | 0.146 0.023 CID_104223 | CID_104223 | |
| 0.027 | 0.015 | 0.034 | Acid ceramidase inhibitor | 0.034 0.006 CID_104223 | CID_104223 | |
| 0.07 | 0.058 | 0.095 | Protein kinase B gamma inhibitor | 0.095 0.035 CID_104223 | CID_104223 | |
| 0.059 | 0.047 | 0.089 | NMDA 2C receptor antagonist | 0.089 0.02 CID_104223 | CID_104223 | |
| 0.037 | 0.026 | 0.049 | Delayed rectifier potassium channel blocker | 0.049 0.012 CID_104223 | CID_104223 | |
| 0.029 | 0.018 | 0.03 | LFA antagonist | 0.03 0.015 CID_104223 | CID_104223 | |
| 0.019 | 0.008 | 0.019 | Dipeptidyl peptidase VIII inhibitor | |||
| 0.039 | 0.028 | 0.039 | AMPA 4 receptor antagonist | |||
| 0.026 | 0.016 | 0.026 | Vanilloid 2 agonist | 0.023 0.022 CID_104223 | ||
| 0.194 | 0.184 | 0.194 | Vasodilator, peripheral | |||
| 0.127 | 0.117 | 0.144 | Arachidonic acid antagonist | 0.144 0.096 CID_104223 | CID_104223 | |
| 0.141 | 0.131 | 0.154 | Succinate dehydrogenase inhibitor | 0.154 0.105 CID_104223 | CID_104223 | |
| 0.02 | 0.01 | 0.02 | Aminopeptidase A inhibitor | |||
| 0.149 | 0.14 | 0.149 | Aldehyde oxidase inhibitor | |||
| 0.039 | 0.029 | 0.039 | Glucagon-like peptide 1 receptor antagonist | |||
| 0.067 | 0.058 | 0.08 | Thrombin inhibitor | 0.08 0.041 CID_104223 | CID_104223 | |
| 0.027 | 0.019 | 0.027 | Baculoviral IAP repeat-containing protein 4 inhibitor | |||
| 0.06 | 0.051 | 0.06 | Neutrophil collagenase inhibitor | |||
| 0.085 | 0.076 | 0.098 | ABCA1 expression enhancer | 0.098 0.053 CID_104223 | CID_104223 | |
| 0.04 | 0.031 | 0.04 | Growth hormone release inhibitor | 0.038 0.035 CID_104223 | ||
| 0.032 | 0.023 | 0.036 | Vanilloid 4 antagonist | 0.036 0.016 CID_104223 | CID_104223 | |
| 0.022 | 0.013 | 0.022 | Neuraminidase (Influenza B) inhibitor | 0.021 0.014 CID_104223 | ||
| 0.062 | 0.054 | 0.073 | Nav1.7 sodium channel blocker | 0.073 0.04 CID_104223 | CID_104223 | |
| 0.021 | 0.014 | 0.021 | Neurokinin 1 agonist | |||
| 0.129 | 0.122 | 0.129 | LIM domain kinase 1 inhibitor | |||
| 0.014 | 0.007 | 0.014 | Glutamate (mGluR6) agonist | |||
| 0.015 | 0.008 | 0.015 | Lysophosphatidic acid receptor 3 agonist | 0.014 0.009 CID_104223 | ||
| 0.026 | 0.019 | 0.028 | Urotensin II agonist | 0.028 0.017 CID_104223 | CID_104223 | |
| 0.102 | 0.095 | 0.103 | Sphingosine 1-phosphate receptor 2 agonist | 0.103 0.094 CID_104223 | CID_104223 | |
| 0.041 | 0.034 | 0.041 | NMDA receptor subunit 3B antagonist | 0.039 0.037 CID_104223 | ||
| 0.022 | 0.016 | 0.022 | Bombesin agonist | |||
| 0.029 | 0.022 | 0.029 | Trypsin II inhibitor | |||
| 0.206 | 0.2 | 0.322 | GABA C receptor rho-3 antagonist | 0.322 0.102 CID_104223 | CID_104223 | |
| 0.054 | 0.048 | 0.056 | Botulinum neurotoxin type A inhibitor | 0.056 0.044 CID_104223 | CID_104223 | |
| 0.071 | 0.066 | 0.102 | GABA B receptor agonist | 0.102 0.015 CID_104223 | CID_104223 | |
| 0.043 | 0.038 | 0.055 | Melanocortin antagonist | 0.055 0.024 CID_104223 | CID_104223 | |
| 0.032 | 0.027 | 0.048 | Retinoid X alpha receptor agonist | 0.048 0.015 CID_104223 | CID_104223 | |
| 0.058 | 0.053 | 0.063 | Trypsin inhibitor | 0.063 0.041 CID_104223 | CID_104223 | |
| 0.038 | 0.034 | 0.038 | Neurokinin 2 agonist | |||
| 0.042 | 0.037 | 0.074 | Urokinase inhibitor | 0.074 0.023 CID_104223 | CID_104223 | |
| 0.031 | 0.027 | 0.032 | Carboxypeptidase B inhibitor | 0.032 0.024 CID_104223 | CID_104223 | |
| 0.066 | 0.062 | 0.066 | Phospholipase D inhibitor | |||
| 0.07 | 0.066 | 0.07 | Vanilloid 4 agonist | |||
| 0.065 | 0.061 | 0.154 | Porphobilinogen synthase inhibitor | 0.154 0.02 CID_104223 | CID_104223 | |
| 0.037 | 0.034 | 0.037 | Complement C3a chemotactic receptor antagonist | |||
| 0.045 | 0.042 | 0.057 | Histamine H4 receptor antagonist | 0.057 0.021 CID_104223 | CID_104223 | |
| 0.046 | 0.043 | 0.046 | Cytokine production stimulant | |||
| 0.037 | 0.035 | 0.04 | Melanocortin 4 antagonist | 0.04 0.031 CID_104223 | CID_104223 | |
| 0.039 | 0.037 | 0.039 | Nicotinic receptor alpha3 subunit antagonist | |||
| 0.014 | 0.012 | 0.023 | Microsomal triglyceride transfer protein inhibitor | 0.023 0.006 CID_104223 | CID_104223 | |
| 0.117 | 0.115 | 0.117 | Insulin secretagoues | |||
| 0.018 | 0.016 | 0.018 | Bombesin 3 receptor agonist | |||
| 0.033 | 0.031 | 0.033 | Adenosine uptake inhibitor | |||
| 0.041 | 0.039 | 0.041 | Antimetabolite | |||
| 0.031 | 0.029 | 0.031 | Free fatty acid receptor 1 antagonist | 0.031 0.029 CID_104223 | ||
| 0.057 | 0.055 | 0.057 | Caspase 9 inhibitor | |||
| 0.006 | 0.005 | 0.007 | CC chemokine 6 receptor agonist | 0.007 0.004 CID_104223 | CID_104223 | |
| 0.045 | 0.044 | 0.045 | Ribonucleoside-diphosphate reductase inhibitor | |||
| 0.053 | 0.052 | 0.053 | Androgen agonist | |||
| 0.073 | 0.072 | 0.073 | Neuropeptide Y antagonist | |||
| 0.021 | 0.02 | 0.021 | Isoleucine-tRNA ligase inhibitor | |||
| 0.027 | 0.027 | 0.047 | Purinergic P2Y14 antagonist | 0.047 0.008 CID_104223 | CID_104223 | |
| 0.057 | 0.059 | 0.066 | Acetylcholine M5 receptor agonist | 0.066 0.049 CID_104223 | CID_104223 | |
| 0.026 | 0.027 | 0.027 | Peptide deformylase inhibitor | 0.027 0.025 CID_104223 | CID_104223 | |
| 0.023 | 0.025 | 0.032 | Histamine H3 receptor agonist | 0.032 0.016 CID_104223 | CID_104223 | |
| 0.038 | 0.041 | 0.062 | Plasmin inhibitor | 0.062 0.027 CID_104223 | CID_104223 | |
| 0.078 | 0.081 | 0.093 | Triose-phosphate isomerase inhibitor | 0.093 0.055 CID_104223 | CID_104223 | |
| 0.043 | 0.048 | 0.052 | Beta 2 adrenoreceptor antagonist | 0.052 0.034 CID_104223 | CID_104223 | |
| 0.058 | 0.063 | 0.062 | Beta 3 adrenoreceptor antagonist | 0.062 0.05 CID_104223 | CID_104223 | |
| 0.029 | 0.034 | 0.047 | Somatostatin 5 agonist | 0.047 0.014 CID_104223 | CID_104223 | |
| 0.033 | 0.038 | 0.076 | Vascular adhesion protein 1 inhibitor | 0.076 0.005 CID_104223 | CID_104223 | |
| 0.093 | 0.099 | 0.119 | Acetylcholine muscarinic antagonist | 0.119 0.068 CID_104223 | CID_104223 | |
| 0.055 | 0.062 | 0.103 | Vanilloid 1 antagonist | 0.103 0.025 CID_104223 | CID_104223 | |
| 0.031 | 0.038 | 0.035 | Somatostatin 4 agonist | 0.035 0.028 CID_104223 | CID_104223 | |
| 0.036 | 0.044 | 0.049 | Geranyltranstransferase inhibitor | 0.049 0.024 CID_104223 | CID_104223 | |
| 0.086 | 0.094 | 0.136 | AMP-activated protein kinase stimulant | 0.136 0.037 CID_104223 | CID_104223 | |
| 0.025 | 0.033 | 0.03 | Estrogen-related receptor gamma antagonist | 0.03 0.016 CID_104223 | CID_104223 | |
| 0.076 | 0.085 | 0.083 | NADH dehydrogenase inhibitor | 0.083 0.069 CID_104223 | CID_104223 | |
| 0.021 | 0.031 | 0.04 | Liver X receptor beta antagonist | 0.04 0.013 CID_104223 | CID_104223 | |
| 0.043 | 0.054 | 0.046 | CD45 antagonist | 0.046 0.044 CID_104223 | CID_104223 | |
| 0.057 | 0.068 | 0.067 | Transcription factor RelA inhibitor | 0.067 0.036 CID_104223 | CID_104223 | |
| 0.062 | 0.074 | 0.107 | 5 Hydroxytryptamine 2A antagonist | 0.107 0.043 CID_104223 | CID_104223 | |
| 0.028 | 0.04 | 0.039 | Potassium channel KCNQ activator | 0.039 0.023 CID_104223 | CID_104223 | |
| 0.028 | 0.04 | 0.039 | Delayed rectifier potassium channel activator | 0.039 0.023 CID_104223 | CID_104223 | |
| 0.017 | 0.03 | 0.029 | Prostaglandin F2 alpha agonist | 0.029 0.01 CID_104223 | CID_104223 | |
| 0.111 | 0.124 | 0.121 | Anticoagulant | 0.121 0.111 CID_104223 | CID_104223 | |
| 0.022 | 0.036 | 0.032 | Somatostatin agonist | 0.032 0.022 CID_104223 | CID_104223 | |
| 0.046 | 0.06 | 0.062 | Biliverdin reductase inhibitor | 0.062 0.039 CID_104223 | CID_104223 | |
| 0.013 | 0.027 | 0.025 | Apolipoprotein B inhibitor | 0.025 0.01 CID_104223 | CID_104223 | |
| 0.057 | 0.072 | 0.09 | Vanilloid antagonist | 0.09 0.041 CID_104223 | CID_104223 | |
| 0.015 | 0.03 | 0.044 | Imidazoline I1 receptor antagonist | 0.044 0.004 CID_104223 | CID_104223 | |
| 0.012 | 0.027 | 0.019 | Histamine H4 receptor agonist | 0.019 0.012 CID_104223 | CID_104223 | |
| 0.013 | 0.028 | 0.019 | Apolipoprotein B-100 inhibitor | 0.019 0.012 CID_104223 | CID_104223 | |
| 0.026 | 0.042 | 0.05 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.05 0.009 CID_104223 | CID_104223 | |
| 0.102 | 0.118 | 0.172 | Protein kinase stimulant | 0.172 0.054 CID_104223 | CID_104223 | |
| 0.014 | 0.031 | 0.019 | Estrogen-related receptor gamma agonist | 0.019 0.013 CID_104223 | CID_104223 | |
| 0.018 | 0.035 | 0.024 | Lysine carboxypeptidase inhibitor | 0.024 0.022 CID_104223 | CID_104223 | |
| 0.016 | 0.034 | 0.021 | Beta 1 adrenoreceptor agonist | 0.021 0.018 CID_104223 | CID_104223 | |
| 0.014 | 0.033 | 0.018 | Alpha 2b adrenoreceptor agonist | 0.018 0.015 CID_104223 | CID_104223 | |
| 0.026 | 0.046 | 0.031 | Peroxisome proliferator-activated receptor delta antagonist | 0.031 0.027 CID_104223 | CID_104223 | |
| 0.03 | 0.051 | 0.046 | Liver X receptor alpha agonist | 0.046 0.023 CID_104223 | CID_104223 | |
| 0.105 | 0.126 | 0.128 | Diuretic | 0.128 0.096 CID_104223 | CID_104223 | |
| 0.053 | 0.074 | 0.062 | Interferon inducer | 0.062 0.049 CID_104223 | CID_104223 | |
| 0.021 | 0.043 | 0.028 | Liver X receptor alpha antagonist | 0.028 0.021 CID_104223 | CID_104223 | |
| 0.041 | 0.063 | 0.068 | Beta 1 adrenoreceptor antagonist | 0.068 0.028 CID_104223 | CID_104223 | |
| 0.059 | 0.082 | 0.072 | MDM2 inhibitor | 0.072 0.034 CID_104223 | CID_104223 | |
| 0.042 | 0.065 | 0.05 | Alpha-mannosidase inhibitor | 0.05 0.045 CID_104223 | CID_104223 | |
| 0.04 | 0.063 | 0.076 | Alcohol oxidase inhibitor | 0.076 0.026 CID_104223 | CID_104223 | |
| 0.071 | 0.095 | 0.091 | Ca(v)3.1 blocker | 0.091 0.035 CID_104223 | CID_104223 | |
| 0.049 | 0.073 | 0.06 | Ca(v)3.2 blocker | 0.06 0.039 CID_104223 | CID_104223 | |
| 0.049 | 0.074 | 0.065 | Alpha adrenoreceptor agonist | 0.065 0.05 CID_104223 | CID_104223 | |
| 0.034 | 0.059 | 0.055 | Potassium channel small-conductance Ca-activated blocker | 0.055 0.02 CID_104223 | CID_104223 | |
| 0.05 | 0.075 | 0.07 | Beta adrenoreceptor antagonist | 0.07 0.038 CID_104223 | CID_104223 | |
| 0.038 | 0.066 | 0.08 | Dopamine beta hydroxylase inhibitor | 0.08 0.005 CID_104223 | CID_104223 | |
| 0.019 | 0.047 | 0.032 | Retinoid X receptor agonist | 0.032 0.028 CID_104223 | CID_104223 | |
| 0.016 | 0.044 | 0.031 | Melanocortin 5 antagonist | 0.031 0.015 CID_104223 | CID_104223 | |
| 0.02 | 0.048 | 0.025 | Thymidine phosphorylase inhibitor | 0.025 0.021 CID_104223 | CID_104223 | |
| 0.053 | 0.081 | 0.062 | Potassium channel (ATP-sensitive) blocker | 0.062 0.057 CID_104223 | CID_104223 | |
| 0.036 | 0.066 | 0.054 | Acyl-CoA dehydrogenase inhibitor | 0.054 0.038 CID_104223 | CID_104223 | |
| 0.025 | 0.055 | 0.063 | Alpha 1d adrenoreceptor agonist | 0.063 0.009 CID_104223 | CID_104223 | |
| 0.061 | 0.092 | 0.165 | Carbonic anhydrase VI inhibitor | 0.165 0.018 CID_104223 | CID_104223 | |
| 0.061 | 0.092 | 0.074 | Interferon agonist | 0.074 0.063 CID_104223 | CID_104223 | |
| 0.129 | 0.161 | 0.156 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.156 0.12 CID_104223 | CID_104223 | |
| 0.073 | 0.105 | 0.084 | UDP-glucose 4-epimerase inhibitor | 0.084 0.082 CID_104223 | CID_104223 | |
| 0.018 | 0.05 | 0.029 | Liver X receptor antagonist | 0.029 0.024 CID_104223 | CID_104223 | |
| 0.03 | 0.063 | 0.045 | Liver X receptor agonist | 0.045 0.028 CID_104223 | CID_104223 | |
| 0.015 | 0.05 | 0.02 | Factor XIII inhibitor | 0.02 0.015 CID_104223 | CID_104223 | |
| 0.03 | 0.066 | 0.043 | Mannosidase inhibitor | 0.043 0.034 CID_104223 | CID_104223 | |
| 0.152 | 0.189 | 0.197 | Peptidyltransferase inhibitor | 0.197 0.103 CID_104223 | CID_104223 | |
| 0.018 | 0.056 | 0.03 | Peroxisome proliferator-activated receptor delta agonist | 0.03 0.028 CID_104223 | CID_104223 | |
| 0.041 | 0.079 | 0.099 | 5 Hydroxytryptamine 1D antagonist | 0.099 0.023 CID_104223 | CID_104223 | |
| 0.026 | 0.065 | 0.042 | GABA uptake inhibitor | 0.042 0.023 CID_104223 | CID_104223 | |
| 0.03 | 0.07 | 0.04 | AICAR transformylase inhibitor | 0.04 0.038 CID_104223 | CID_104223 | |
| 0.033 | 0.074 | 0.044 | Cholesterol esterase inhibitor | 0.044 0.041 CID_104223 | CID_104223 | |
| 0.019 | 0.06 | 0.033 | Liver X receptor beta agonist | 0.033 0.024 CID_104223 | CID_104223 | |
| 0.046 | 0.088 | 0.133 | 5 Hydroxytryptamine 5A antagonist | 0.133 0.009 CID_104223 | CID_104223 | |
| 0.031 | 0.073 | 0.042 | Dihydrofolate reductase inhibitor | 0.042 0.035 CID_104223 | CID_104223 | |
| 0.045 | 0.088 | 0.065 | Potassium channel (Ca-activated) blocker | 0.065 0.033 CID_104223 | CID_104223 | |
| 0.037 | 0.08 | 0.051 | Leukotriene B4 antagonist | 0.051 0.042 CID_104223 | CID_104223 | |
| 0.021 | 0.065 | 0.059 | Carbonic anhydrase I stimulant | 0.059 0.012 CID_104223 | CID_104223 | |
| 0.065 | 0.11 | 0.073 | MAP kinase kinase 7 inhibitor | 0.073 0.071 CID_104223 | CID_104223 | |
| 0.008 | 0.054 | 0.017 | Alpha 2a adrenoreceptor agonist | 0.017 0.012 CID_104223 | CID_104223 | |
| 0.079 | 0.127 | 0.105 | Acetylcholine antagonist | 0.105 0.085 CID_104223 | CID_104223 | |
| 0.015 | 0.063 | 0.047 | Leukotriene A4 hydrolase inhibitor | 0.047 0.022 CID_104223 | CID_104223 | |
| 0.041 | 0.089 | 0.079 | 5 Hydroxytryptamine 1B antagonist | 0.079 0.035 CID_104223 | CID_104223 | |
| 0.08 | 0.129 | 0.107 | Cholinergic antagonist | 0.107 0.087 CID_104223 | CID_104223 | |
| 0.072 | 0.121 | 0.236 | 5 Hydroxytryptamine 3A agonist | 0.236 0.007 CID_104223 | CID_104223 | |
| 0.054 | 0.104 | 0.086 | Protein kinase A inhibitor | 0.086 0.055 CID_104223 | CID_104223 | |
| 0.076 | 0.126 | 0.097 | Cholesterol synthesis inhibitor | 0.097 0.091 CID_104223 | CID_104223 | |
| 0.037 | 0.088 | 0.065 | Carbonic anhydrase II stimulant | 0.065 0.018 CID_104223 | CID_104223 | |
| 0.044 | 0.097 | 0.057 | I kappa B kinase 2 inhibitor | 0.057 0.053 CID_104223 | CID_104223 | |
| 0.04 | 0.094 | 0.132 | 5 Hydroxytryptamine 5 antagonist | 0.132 0.01 CID_104223 | CID_104223 | |
| 0.038 | 0.092 | 0.064 | Calcium channel T-type blocker | 0.064 0.033 CID_104223 | CID_104223 | |
| 0.077 | 0.133 | 0.137 | Glutamate receptor antagonist | 0.137 0.06 CID_104223 | CID_104223 | |
| 0.017 | 0.073 | 0.041 | Phosphoglycerate kinase inhibitor | 0.041 0.019 CID_104223 | CID_104223 | |
| 0.034 | 0.091 | 0.074 | 5 Hydroxytryptamine 6 antagonist | 0.074 0.027 CID_104223 | CID_104223 | |
| 0.037 | 0.095 | 0.063 | Alpha 2 adrenoreceptor agonist | 0.063 0.039 CID_104223 | CID_104223 | |
| 0.081 | 0.142 | 0.108 | Acetylcholine release stimulant | 0.108 0.071 CID_104223 | CID_104223 | |
| 0.05 | 0.113 | 0.071 | Acetylcholine nicotinic antagonist | 0.071 0.067 CID_104223 | CID_104223 | |
| 0.109 | 0.173 | 0.124 | MAP kinase 3 inhibitor | 0.124 0.123 CID_104223 | CID_104223 | |
| 0.068 | 0.135 | 0.081 | T cell inhibitor | 0.081 0.062 CID_104223 | CID_104223 | |
| 0.139 | 0.206 | 0.29 | 5 Hydroxytryptamine 1E antagonist | 0.29 0.036 CID_104223 | CID_104223 | |
| 0.022 | 0.09 | 0.11 | Carbonic anhydrase VB inhibitor | 0.11 0.014 CID_104223 | CID_104223 | |
| 0.036 | 0.105 | 0.062 | Cannabinoid CB1 receptor antagonist | 0.062 0.042 CID_104223 | CID_104223 | |
| 0.028 | 0.099 | 0.093 | Toll-Like receptor 8 antagonist | 0.093 0.012 CID_104223 | CID_104223 | |
| 0.022 | 0.096 | 0.051 | Stearoyl-CoA desaturase inhibitor | 0.051 0.023 CID_104223 | CID_104223 | |
| 0.04 | 0.114 | 0.077 | Na+ K+ transporting ATPase inhibitor | 0.077 0.053 CID_104223 | CID_104223 | |
| 0.131 | 0.206 | 0.21 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.21 0.064 CID_104223 | CID_104223 | |
| 0.029 | 0.106 | 0.06 | Acetylcholine M3 receptor antagonist | 0.06 0.041 CID_104223 | CID_104223 | |
| 0.018 | 0.095 | 0.039 | Dihydropteroate synthase inhibitor | 0.039 0.028 CID_104223 | CID_104223 | |
| 0.055 | 0.135 | 0.113 | Histamine H2 receptor antagonist | 0.113 0.025 CID_104223 | CID_104223 | |
| 0.018 | 0.098 | 0.039 | Tryptase inhibitor | 0.039 0.023 CID_104223 | CID_104223 | |
| 0.035 | 0.12 | 0.067 | Cannabinoid receptor antagonist | 0.067 0.053 CID_104223 | CID_104223 | |
| 0.013 | 0.099 | 0.047 | Carbonic anhydrase IV inhibitor | 0.047 0.026 CID_104223 | CID_104223 | |
| 0.032 | 0.122 | 0.066 | 5 Hydroxytryptamine 1 antagonist | 0.066 0.058 CID_104223 | CID_104223 | |
| 0.007 | 0.098 | 0.059 | 5 Hydroxytryptamine 1D agonist | 0.059 0.008 CID_104223 | CID_104223 | |
| 0.122 | 0.217 | 0.293 | Cardiotonic | 0.293 0.059 CID_104223 | CID_104223 | |
| 0.095 | 0.193 | 0.13 | GABA C receptor rho-2 antagonist | 0.13 0.105 CID_104223 | CID_104223 | |
| 0.032 | 0.131 | 0.109 | Carbonic anhydrase VA inhibitor | 0.109 0.021 CID_104223 | CID_104223 | |
| 0.044 | 0.144 | 0.079 | Macrophage migration inhibitory factor inhibitor | 0.079 0.052 CID_104223 | CID_104223 | |
| 0.089 | 0.191 | 0.128 | Cyclin-dependent kinase 8 inhibitor | 0.128 0.105 CID_104223 | CID_104223 | |
| 0.027 | 0.13 | 0.075 | CXC chemokine 4 receptor antagonist | 0.075 0.033 CID_104223 | CID_104223 | |
| 0.114 | 0.219 | 0.182 | Death-associated protein kinase 2 inhibitor | 0.182 0.052 CID_104223 | CID_104223 | |
| 0.071 | 0.176 | 0.107 | Protein kinase (CK1) gamma inhibitor | 0.107 0.106 CID_104223 | CID_104223 | |
| 0.022 | 0.128 | 0.057 | 5 Hydroxytryptamine 1A antagonist | 0.057 0.056 CID_104223 | CID_104223 | |
| 0.034 | 0.139 | 0.116 | Carbonic anhydrase XIII inhibitor | 0.116 0.031 CID_104223 | CID_104223 | |
| 0.049 | 0.156 | 0.096 | 5 Hydroxytryptamine antagonist | 0.096 0.082 CID_104223 | CID_104223 | |
| 0.028 | 0.136 | 0.111 | Carbonic anhydrase V inhibitor | 0.111 0.024 CID_104223 | CID_104223 | |
| 0.118 | 0.231 | 0.152 | Growth factor agonist | 0.152 0.138 CID_104223 | CID_104223 | |
| 0.095 | 0.211 | 0.143 | Tumour necrosis factor antagonist | 0.143 0.11 CID_104223 | CID_104223 | |
| 0.028 | 0.153 | 0.329 | 5 Hydroxytryptamine 1B agonist | 0.329 0.004 CID_104223 | CID_104223 | |
| 0.026 | 0.169 | 0.071 | Amidase inhibitor | 0.071 0.048 CID_104223 | CID_104223 | |
| 0.03 | 0.175 | 0.083 | 5 Hydroxytryptamine 3 agonist | 0.083 0.024 CID_104223 | CID_104223 | |
| 0.064 | 0.211 | 0.14 | NADPH oxidase inhibitor | 0.14 0.062 CID_104223 | CID_104223 | |
| 0.01 | 0.158 | 0.041 | Carbonic anhydrase VII inhibitor | 0.041 0.039 CID_104223 | CID_104223 | |
| 0.108 | 0.258 | 0.171 | DNA damaging | 0.171 0.144 CID_104223 | CID_104223 | |
| 0.019 | 0.174 | 0.048 | Protein kinase C epsilon inhibitor | 0.048 0.043 CID_104223 | CID_104223 | |
| 0.147 | 0.304 | 0.229 | Antibacterial | 0.229 0.197 CID_104223 | CID_104223 | |
| 0.025 | 0.186 | 0.071 | Histamine H1 receptor antagonist | 0.071 0.068 CID_104223 | CID_104223 | |
| 0.01 | 0.179 | 0.239 | 5 Hydroxytryptamine 1 agonist | 0.239 0.009 CID_104223 | CID_104223 | |
| 0.055 | 0.231 | 0.237 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.237 0.035 CID_104223 | CID_104223 | |
| 0.083 | 0.264 | 0.221 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.221 0.066 CID_104223 | CID_104223 | |
| 0.059 | 0.245 | 0.158 | Toll-Like receptor antagonist | 0.158 0.05 CID_104223 | CID_104223 | |
| 0.015 | 0.216 | 0.063 | 5 Hydroxytryptamine 7 antagonist | 0.063 0.042 CID_104223 | CID_104223 | |
| 0.04 | 0.252 | 0.101 | GABA receptor agonist | 0.101 0.076 CID_104223 | CID_104223 | |
| 0.019 | 0.245 | 0.068 | CXC chemokine receptor antagonist | 0.068 0.053 CID_104223 | CID_104223 | |
| 0.06 | 0.291 | 0.197 | HERG channel blocker | 0.197 0.092 CID_104223 | CID_104223 | |
| 0.061 | 0.3 | 0.196 | Potassium channel (Voltage-sensitive) blocker | 0.196 0.099 CID_104223 | CID_104223 | |
| 0.049 | 0.295 | 0.096 | Toll-Like receptor 3 antagonist | 0.096 0.057 CID_104223 | CID_104223 | |
| 0.005 | 0.274 | 0.027 | Melatonin antagonist | 0.027 0.021 CID_104223 | CID_104223 | |
| 0.019 | 0.362 | 0.162 | M18 aspartyl aminopeptidase inhibitor | 0.162 0.047 CID_104223 | CID_104223 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |